Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis A Fernandez

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Turkish Journal of Medical Sciences|October 10, 2020
A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matterYücel Yankol, Emily Bugeaud, Tiffany Zens, et al.
Transplantation|July 22, 2006
A significant role for histocompatibility in human islet transplantationT Mohanakumar, Kishore Narayanan, Niraj Desai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 2, 2012
Differential outcomes of expanded-criteria donor renal allografts according to recipient ageJoshua D Mezrich, John D Pirsch, Luis A Fernandez, et al.
Transplantation|December 20, 2002
Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation modelLuis A Fernandez, Jose Torrealba, Gökhan Yagci, et al.
Annals of Surgery|October 26, 2005
Donation after cardiac death: the University of Wisconsin experience with liver transplantationDavid P Foley, Luis A Fernandez, Glen Leverson, et al.
Annals of Surgery|October 26, 2005
Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomesLuis A Fernandez, Antonio Di Carlo, Jon S Odorico, et al.
Molecular Endocrinology (Baltimore, Md.)|July 28, 2010
FoxM1 is up-regulated by obesity and stimulates beta-cell proliferationDawn Belt Davis, Jeremy A Lavine, Joshua I Suhonen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Chronic kidney disease stage progression in liver transplant recipientsJohn C Lamattina, David P Foley, Joshua D Mezrich, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 5, 2006
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantationRolf N Barth, Christina A Janus, Christine A Lillesand, et al.
Surgery|October 18, 2011
Donation after cardiac death: a 29-year experienceJanet M Bellingham, Chandrasekar Santhanakrishnan, Nikole Neidlinger, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Turkish Journal of Medical Sciences|October 10, 2020
A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matterYücel Yankol, Emily Bugeaud, Tiffany Zens, et al.
Transplantation|July 22, 2006
A significant role for histocompatibility in human islet transplantationT Mohanakumar, Kishore Narayanan, Niraj Desai, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 2, 2012
Differential outcomes of expanded-criteria donor renal allografts according to recipient ageJoshua D Mezrich, John D Pirsch, Luis A Fernandez, et al.
Transplantation|December 20, 2002
Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation modelLuis A Fernandez, Jose Torrealba, Gökhan Yagci, et al.
Annals of Surgery|October 26, 2005
Donation after cardiac death: the University of Wisconsin experience with liver transplantationDavid P Foley, Luis A Fernandez, Glen Leverson, et al.
Annals of Surgery|October 26, 2005
Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomesLuis A Fernandez, Antonio Di Carlo, Jon S Odorico, et al.
Molecular Endocrinology (Baltimore, Md.)|July 28, 2010
FoxM1 is up-regulated by obesity and stimulates beta-cell proliferationDawn Belt Davis, Jeremy A Lavine, Joshua I Suhonen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2011
Chronic kidney disease stage progression in liver transplant recipientsJohn C Lamattina, David P Foley, Joshua D Mezrich, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 5, 2006
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantationRolf N Barth, Christina A Janus, Christine A Lillesand, et al.
Surgery|October 18, 2011
Donation after cardiac death: a 29-year experienceJanet M Bellingham, Chandrasekar Santhanakrishnan, Nikole Neidlinger, et al.
Pageof 7